Skip to content
healthcare.dev
Get a free key

DAPAGLIFLOZIN

NDC 71921-420, Dapagliflozin, tablet, from Florida Pharmaceutical Products, LLC.

Product NDC
71921-420
Status
Listed
Labeler
Florida Pharmaceutical Products, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211156
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71921-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
71921-420-097192104200990 TABLET in 1 BOTTLE (71921-420-09)
71921-420-337192104203330 TABLET in 1 BOTTLE (71921-420-33)
71921-420-5071921042050500 TABLET in 1 BOTTLE (71921-420-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/20a83ea2-6ad8-4bbb-b516-73c0a9e37399

  • NADAC price for package 71921042033

    GET /v1/drugs/nadac/71921042033

Use it

Look up 71921-420 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71921-420 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71921-420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.